Treatment of multi drug resistant gram negative bacilli with inhaled polymyxin-b

Authors

  • Suresh Kumar Konkyana Department of Anesthesiology, Osmania Medical College/MGMH, Hyderabad, India
  • Anil Kumar Akkenapalli Department of Anesthesiology, Osmania Medical College/MGMH, Hyderabad, India

DOI:

https://doi.org/10.21276/apjhs.2016.3.3.21

Keywords:

Polymyxin-B, Bronchospasm, Nephotoxicity

Abstract

Introduction: A major challenge has arisen regarding the treatment of infections caused by Gram-negative bacilli, particularly those with high level intrinsic resistance to many antibiotic classes and extreme ability to acquire resistance. Aim: The present study was conducted to assess the safety and efficacy of aerosolized polymyxin-B in comparison to intravenous polymyxin-B therapy for treatment of MDR GNB. Materials and methods: Study was performed over a period of 18 months. A Comparative two group randomized clinical study with 50 patients with 25 patients in Group A and 25 patients in Group-B is undertaken to study the outcome of therapy, fever response to therapy and side effects. Results: Mean duration of ICU stay was 28.68±9.15 days in Group-A while it was 31.64±9.16 days in Group-B. This was not statistically significant with p-value 0.258786. Pseudomonas aeruginosa is the most common organism isolated .In this study improvement, cure and failure rates were 44%, 44% and 12% respectively in Group-A(inhaled polymyxin b). while improvement,cure and failure rates were 40%,20% and 40% in Group-B(iv Polymyxin B) which was statistically significant. fever response to study was better in Group-A (inhaled polymyxin B) which was statistically significant. Adverse events to polymyxin B Inhalation (bronchospasm) occurred in 16% of the patients in group-A , Nephotoxicity in 28% of patients in group –B.but did not lead to suspension of treatment. Conclusion: Inhaled polymyxin-B was useful in treatment of nosocomial pneumonia caused by MDR-GNB in mechanically ventilated patients. As the drug is given by inhalational route systemic side effects can be minimized.

Downloads

Download data is not yet available.

Author Biographies

Suresh Kumar Konkyana, Department of Anesthesiology, Osmania Medical College/MGMH, Hyderabad, India

Assistant Professor, 

Anil Kumar Akkenapalli, Department of Anesthesiology, Osmania Medical College/MGMH, Hyderabad, India

Assistant Professor,

Downloads

Published

2016-09-30

How to Cite

Suresh Kumar Konkyana, & Anil Kumar Akkenapalli. (2016). Treatment of multi drug resistant gram negative bacilli with inhaled polymyxin-b. Asian Pacific Journal of Health Sciences, 3(3), 135–141. https://doi.org/10.21276/apjhs.2016.3.3.21